New Antiviral, Antibacterial and Antifungal Agents
Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.
- Mechanisms of action, preclinical data & pharmacology
- Pharmacokinetics/pharmacodynamics
- Clinical trials
- Pharmacoepidemiology
- New technologies in the development
- Prescribing Improved agents
- Advancement
Related Conference of New Antiviral, Antibacterial and Antifungal Agents
September 27-29, 2018
10th Euro-Global Conference on Infectious Diseases
Rome, Italy (Holiday Inn Rome Eur Parco dei Medici)
November 12-13, 2018
8th Asia Pacific STD and Infectious Diseases Congress
Hotel Radisson , Tokyo Japan
November 19-20, 2018
International Conference on Clinical Microbiology, Virology and Infectious Diseases
Bucharest, Romania
November 19-20, 2018
International Conference on Antimicrobial and Antibacterial Agents
Bucharest, Romania
November 22-23, 2018
8th International Conference on Bacteriology and Infectious Diseases
Cape Town, South Africa
March 21-22, 2019
14th International Conference on Infectious Diseases, Prevention and Control
Dubai, UAE
April 08-09, 2019
2nd Global experts meet on STD-AIDS and Infectious Diseases
Wellington, New Zealand
April 10-11, 2019
3rd International Conference on Influenza and Emerging Infectious Diseases
Toronto, Ontario, Canada
May 17-18, 2019
4th International Conference on Infectious Diseases: Control and Prevention
Philadelphia, Pennsylvania, USA
July 01-02, 2019
7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Valencia, Spain
September 16-17, 2019
10th International Conference on Emerging Infectious Diseases
Brussels, Belgium
September 27-28, 2019 Toronto, Canada
6th Annual Congress on Rare Diseases and Orphan Drugs
New Antiviral, Antibacterial and Antifungal Agents Conference Speakers
Recommended Sessions
- Bacterial Genomes and Infectious Diseases:
- Bacterial Infectious Diseases
- Bacterial Susceptibility & Resistance
- Clinical Infectious Disease
- Detection and preventing infections in healthcare
- Drug Interactions in Infectious Diseases
- Ebola Outbreak and Approaches for Prevention
- Emerging Infectious Diseases
- Feline Infectious Diseases
- Fungal Infectious Diseases
- Infectious Agents and the Human Immune Response
- Infectious Disease Epidemiology
- Infectious Diseases and Arthropods
- Infectious Diseases and Pathology
- Infectious Diseases and Tropical Medicine
- Infectious Diseases in Africa
- Infectious Diseases in America
- Infectious Diseases in Asia
- Infectious Diseases in Children
- Infectious Diseases in Critical Care Medicine
- Infectious Diseases in Europe
- Infectious Diseases in UK
- Infectious Diseases of Humans
- Infectious Diseases of Livestock
- Infectious Diseases of the Female Genital Tract
- Infectious Diseases: Worms, Prions, and Fungi
- Laboratory Diagnosis of Infectious Diseases
- Market Trends Of Infectious Diseases
- Medical Pioneers in Infectious Diseases
- Microbiology and Infectious Diseases
- Molecular Diagnostics of Infectious Diseases
- New Antiviral, Antibacterial and Antifungal Agents
- Nosocomial Infections
- Parasitic Diseases
- Pediatric Infectious Diseases
- Preventing Infectious Diseases
- Protozoal Diseases
- Public health practice
- Respiratory Diseases
- Sexually transmitted Diseases and infection
- Tropical Infectious Diseases
- Vaccines
- Viral Infectious Diseases